Africa: Generic HIV Prevention Injection Moves Closer to 120 Countries After FDA Approval
Nairobi — Access to a twice-yearly HIV prevention injection is moving closer to millions of people in low- and middle-income countries after Dr. Reddy’s Laboratories secured tentative approval from the United States Food and Drug Administration (FDA) for the first generic version of lenacapavir. The regulatory milestone, secured just 16 months after approval of Gilead…